MedPath
NMPA Approval

Tofacitinib Citrate Tablets

国药准字H20243600

April 24, 2024

Drug Information

枸橼酸托法替布片

片剂

5mg(按C₁₆H₂₀N₆O计)

化学药品

April 24, 2024

Company Information

Applicant Company

重庆市渝中区长江二路12号第三层

Manufacturing Company

重庆市南岸经济技术开发区大石支路2号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

枸橼酸托法替布片 - NMPA 批准文号 | MedPath